Episode Details
Back to Episodes
246: Vas Narasimhan on the future of pharma, plus Moderna’s promise & a biotech presidential bid
Published 3 years, 8 months ago
Description
Vas Narasimhan, CEO of Novartis and the new chairman of PhRMA, joins us to discuss the industry’s struggles in Washington and whether the deflated biotech sector is still overvalued. We also dive into the latest news in the life sciences, including Moderna's promise of no-cost Covid-19 vaccines and biotech entrepreneur Vivek Ramaswamy's potential run for president.